Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
- PMID: 40757655
- DOI: 10.1056/NEJMx250003
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Erratum for
-
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.N Engl J Med. 2023 Oct 19;389(16):1453-1465. doi: 10.1056/NEJMoa2303974. N Engl J Med. 2023. PMID: 37851874 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources